Centre National de la Recherche Scientifique (C.N.R.S);Université de la Méditerranée - Aix-Marseille II
发明人:
申请号：
EP10305836.8
公开号：
EP2412724A1
申请日:
2010.07.29
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The present invention thus relates to stem cells or progenitor cells wherein the expression and/or activity of a member of the glypican family is reduced or abolished for use for the treatment of a pathological condition selected from the group consisting of a degenerative disease, a cardiac disorder, a metabolic disease and an injury； by stem cell-based therapy.
